Difficulty with diagnosis of malignant pancreatic neoplasms coexisting with chronic pancreatitis
Open accessThe DOI matches its OpenAlex record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
AIM: To investigate the effects of troglitazone (TGZ), an anti-diabetic drug which activates peroxisome proliferator-activated receptor-gamma (PPAR-gamma), for liver tissue repair, and the development of ductular reaction, following common bile duct ligation (BDL) in rats. METHODS: Rats were supplemented with TGZ (0.2% w/w in the pelleted food) for 1 wk before BDL or sham operation. Animals were killed at 1, 2, or 4 wk after surgery. RESULTS: The development of liver fibrosis was reduced in rats receiving TGZ, as indicated by significant decreases of procollagen type I gene expression and liver hydroxy-proline levels. Accumulation of alpha-smooth-muscle actin (SMA)-expressing cells surrounding newly formed bile ducts following BDL, as well as total hepatic levels of SMA were partially inhibited by TGZ treatment, indicating the presence of a reduced number and/or activation of hepatic stellate cells (HSC) and myofibroblasts. Development of the ductular reaction was inhibited by TGZ, as indicated by histochemical evaluation and hepatic activity of gamma-glutamyl-transferase (GGT). CONCLUSION: Treatment with thiazolidinedione reduces ductular proliferation and fibrosis in a model of chronic cholestasis, and suggests that limiting cholangiocyte proliferation may contribute to the lower development of scarring in this system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Peroxisome proliferator-activated receptors and hepatic stellate cell activation
Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H. F., Motomura, K., Anania, F. A., Willson, T. M., & Tsukamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006577200 · Cited by 473 · cited 2×
“downregulate several biologic actions of activated HSC, which are important for liver wound healing and fibrogenesis, including cell proliferation, migration, extracellular matrix synthesis, and expression of chemokines[ 13-15 ].”
BackgroundGalli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati–Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., & Casini, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33666 · Cited by 440 · cited 1×
“Moreover, data from the present study are in agreement with recently reported findings, demonstrating that other thiazolidinediones inhibit collagen deposition in several models of chronic liver damage, including chronic intoxication with carbon tetrachloride or dimethylnitrosamine, or BDL[28, 29 ].”
ResultMarra, F., Efsen, E., Romanelli, R. G., Caligiuri, A., Pastacaldi, S., Batignani, G., Bonacchi, A., Caporale, R., Laffi, G., Pinzani, M., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.9365 · Cited by 409
Chitturi, S., & George, J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30102 · Cited by 216 · cited 1×
“Although TGZ has been withdrawn from the marked increase because of its severe hepatotoxicity[ 30 ], it is still currently used in animal models or in cell culture systems, to establish a ‘proof of concept’ that may be expanded to other drugs of the same class, such as rosiglitazone or pioglitazone[31,32].”
BackgroundGalli, A., Crabb, D., Price, D., Ceni, E., Salzano, R., Surrenti, C., & Casini, A. (2000) · Hepatology · doi:10.1002/hep.510310117 · Cited by 197 · cited 2×
“downregulate several biologic actions of activated HSC, which are important for liver wound healing and fibrogenesis, including cell proliferation, migration, extracellular matrix synthesis, and expression of chemokines[ 13-15 ].”
BackgroundGilde, A. J., & Van Bilsen, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01161.x · Cited by 178
Kawaguchi, K., Sakaida, I., Tsuchiya, M., Omori, K., Takami, T., & Okita, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.038 · Cited by 160 · cited 1×
“Thiazolidinediones also exert a protective role in other conditions of liver injury, as indicated by the recent findings, showing amelioration of ethanol- or diet-induced liver injury by pioglitazone[ 33-35 ].”
BackgroundPioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met
Tomita, K., Azuma, T., Kitamura, N., Nishida, J., Tamiya, G., Oka, A., Inokuchi, S., Nishimura, T., Suematsu, M., & Ishii, H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.008 · Cited by 141
Research works printed but not linked: 12
- 10.1080/0031302021000035965-3 · DOI
- 10.1097/00006676-200004000-00005 · DOI
- Machado MC, Montagnini AL, Machado MA, Falzoni R, Volpe P, Jukemura J, Abdo EE, Penteado S, Bacchella T, Monteiro-Cunha JE. Cystic neoplasm diagnosed as pancreatic pseudocyst: report of 5 cases and review of the literature. Rev Hosp Clin Fac Med Sao Paulo 1994;49:246-249.
- Civello IM, Frontera D, Viola G, Maria G, Crucitti F. Cystic neoplasm mistaken for pancreatic pseudocyst. Hepatogastroenterology 1996;43:967-970.
- Zalatnai A. Pathologic diagnosis of pancreatic cancer--facts, pitfalls, challenges. Orv Hetil 2001;142:1885-1890.
- Nieman JL, Holmes FF. Accuracy of diagnosis of pancreatic cancer decreases with increasing age. J Am Geriatr Soc 1989;37:97-100. · doi:10.1111/j.1532-5415.1989.tb05866.x
- 10.1038/bjc.1993.469 · doi:10.1038/bjc.1993.469
- 10.1016/0002-9610(79)90024-2 · doi:10.1016/0002-9610(79)90024-2
- Pinto MM, Kaye AD. Fine needle aspiration of cystic liver lesions. Cytologic examination and carcinoembryonic antigen assay of cyst contents. Acta Cytol 1989;33:852-856.
- Safi F, Schlosser W, Falkenreck S, Beger HG. Prognostic value of CA 19-9 serum course in pancreatic cancer. Hepatogastroenterology 1998;45:253-259.
- 10.1148/radiographics.18.2.9536488 · doi:10.1148/radiographics.18.2.9536488
- 10.1053/crad.1999.0341 · doi:10.1053/crad.1999.0341
Cited by
From the metabolic syndrome to NAFLD or vice versa?
Vanni, E., Bugianesi, E., Kotronen, A., De Minicis, S., Yki-Järvinen, H., & Svegliati-Baroni, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.016 · Cited by 497
Patterson, E., O' Doherty, R. M., Murphy, E. F., Wall, R., O' Sullivan, O., Nilaweera, K., Fitzgerald, G. F., Cotter, P. D., Ross, R. P., & Stanton, C. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000117 · Cited by 211
Novel therapeutic targets for cholestatic and fatty liver disease
Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146
“Beneficial effects of troglitazone observed in a rat model of obstructive cholestasis on cholangiocellular proliferation and fibrosis have not yet been extended to other models (Marra et al., 2005).”
Fibrate treatment for primary biliary cirrhosis
Cuperus, F. J. C., Halilbasic, E., & Trauner, M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000056 · Cited by 36
Metadata
- Authors
- Leung, T.-K.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2005
- Volume
- 11
- Issue
- 32
- Pages
- 5075
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W1490260464
- Cited by
- 59
- References
- 11
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Difficulty with diagnosis of malignant pancreatic neoplasms coexisting with chronic pancreatitis. https://app.cochat.ai/papers/10.3748/wjg.v11.i32.4931
- The paper
- Leung, T.-K. (2005). Difficulty with diagnosis of malignant pancreatic neoplasms coexisting with chronic pancreatitis. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v11.i32.4931
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.